VerImmune
2 known investors
VerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity. The company targets cancer patients across a broad range of cancer types.
BiotechHealthtechMedical Devices
Investors · 2
In the news
- VerImmune Secures $4.5 Million to Drive Biotech Innovation | BioBuzzbiobuzz.io · 2024
- VerImmune Closes $4.5M First Closing of Pre-Series A Financingfinsmes.com · 2024
- VerImmune Announces Over $3M Additional Funding — VERIMMUNEverimmune.com · 2023
- VerImmune raises $2.5M to develop virus-inspired particle immunotherapieslabiotech.eu · 2022
- VerImmune Inc Announces Closing of Seed Financing to Further Develop Novel Virus-inspired Particle Immunotherapies — VERIMMUNEverimmune.com · 2022
- VerImmune - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2021